Successful Heart-Lung Transplant for a Patient on Continuous-Flow Left Ventricular Assist Device Support Complicated With Amiodarone-Induced Pulmonary Fibrosis

M E Currie; Y Shudo; J Mooney; Y J Woo

doi:10.1016/j.transproceed.2018.12.024

Successful Heart-Lung Transplant for a Patient on Continuous-Flow Left Ventricular Assist Device Support Complicated With Amiodarone-Induced Pulmonary Fibrosis

Transplant Proc. 2019 Mar;51(2):593-594. doi: 10.1016/j.transproceed.2018.12.024. Epub 2019 Jan 3.

Authors

M E Currie¹, Y Shudo¹, J Mooney², Y J Woo³

Affiliations

¹ Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA.
² Department of Medicine, Division of Pulmonary and Critical Care, Stanford University School of Medicine, Stanford, CA.
³ Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA. Electronic address: joswoo@stanford.edu.

PMID: 30879597
DOI: 10.1016/j.transproceed.2018.12.024

Abstract

In this case report, we present a successful case of en bloc heart-lung transplant in a patient with advanced cardiopulmonary respiratory failure from amiodarone-associated pulmonary fibrosis that occurred post-left ventricular assist device implantation.

Publication types

Case Reports

MeSH terms

Amiodarone / adverse effects
Anti-Arrhythmia Agents / adverse effects
Heart Failure / etiology
Heart Failure / surgery
Heart-Assist Devices*
Heart-Lung Transplantation / methods*
Humans
Male
Middle Aged
Pulmonary Fibrosis / chemically induced*
Respiratory Insufficiency / etiology
Respiratory Insufficiency / surgery
Treatment Outcome

Substances

Anti-Arrhythmia Agents
Amiodarone